US equities |
META $630.56 ▲+0.00% MU $903.70 ▲+0.00% TSLA $391.62 ▲+0.00% NVDA $216.00 ▲+0.00% SPCX $146.90 ▲+0.00% SNDK $1,255.58 ▲+0.00% INTC $90.47 ▲+0.00% SKHY $142.62 ▲+0.00%
FinancialContent

Latest News about XNAS:OKYO

Recent news which mentions XNAS:OKYO

Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
Tickers ALPMF ISEE OKYO VTRS
Tags XNAS:OKYO OKYO Pharma
From TheNewswire.com - RSS (Media)
OKYO Pharma reaches milestone with first patient screening for dry eye disease trial
Tags XLON:OKYO OKYO Pharma Ltd XNAS:OKYO
From TheNewswire.com - RSS (Media)
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
Tickers ALDX OCUL OKYO TARS
Tags XNAS:OKYO OKYO Pharma
From TheNewswire.com - RSS (Media)
Dry Eye Disease Impacts 49 Million Americans And Disproportionately Affects Women, But Current Treatments Aren't Fully Effective – OKYO Pharma's Drug Candidate Could Be The Solution
Tickers ALDX OKYO TARS
Tags XNAS:OKYO OKYO Pharma
From TheNewswire.com - RSS (Media)